Articles
Article
How can new approaches to digitalisation help keep the patient experience in focus?
As the practices in which clinical trials are conducted and monitored continue to modernise at a rapid pace, there is an urgent need for digital transformation in the industry. Encapsia’s Temitope Keyes speaks to International Clinical Trials about new approaches to digitalisation that can help patient experience in focus.
Read more on ICT.
Article
Oncology Decentralized Trials call for special consideration: Encapsia
Encapsia spoke to Outsourcing-Pharma about some of the challenges unique to cancer-focused DCTs, and technologies that can help overcome some of these special obstacles.
Read more on Outsourcing Pharma
Article
The Source and the Story – How Digital Transformation Truly Centers Patients
This article is taken from International Clinical Trials February 2022, pages 8-10 © Samedan Ltd
Article
Predictions and perspectives on the future of DCTs
“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.
Read more on Drug Discovery World
Article
Updates Ready: Reboot Necessary
Clinical trials are now more complex than ever, and technology has not kept pace. Though a shift to digital decentralization has begun, all too often the solutions are just stitched onto already underperforming legacy systems.
Read more on The Medicine Maker
Article
Getting the right tech tools vital to decentralized trial transition
Mark Tomlinson, Senior Director of Technology Operations at encapsia, explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.
Read more on Outsourcing Pharma
Article
Enabling Decentralized Clinical Trials through Digital Transformation
To properly support and enable DCTs, we must undergo a digital transformation; we must eliminate the pain involved in aggregating and integrating data from multiple sources, reduce the lag between data capture and data analysis, and improve the ability of study teams to gain deeper insights and operationalize the data.
Read more on Contract Pharma
Article
Personalized Medicine: A Work in Progress
Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.
Read more on PharmaVoice
Article
Clinical Trials in 3D – DCT, Data Science and Digital Transformation
This article is taken from International Clinical Trials May 2021, pages 50-52. © Samedan Ltd.